Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: An experimental study in a porcine model

European Radiology

Volumn 20, Issue 10, 2010, Pages 2372-2380

  Maleux, Geert ^d   Monbaliu, Diethard ^a   Verslype, Chris ^a   Casteleyn, Christophe ^b   Van De Velde, Marc ^a   Cornillie, Pieter ^b   Hoogeveen, Yvonne ^c   Van Cutsem, Eric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

Animal experiment; Catheter directed procedure; Interventional procedure; Isolated liver perfusion; Liver

Indexed keywords

TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BALLOON OCCLUSION; BLOOD CHEMISTRY; DISEASE MODEL; FEMORAL VEIN; HEMODYNAMICS; HISTOPATHOLOGY; LIVER PERFUSION; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; SWINE; SYSTEMIC CIRCULATION; VEIN BYPASS;

ANGIOGRAPHY; ANIMALS; BALLOON DILATION; CATHETERIZATION; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; HEPATIC VEINS; LIVER; PERFUSION; PORTAL VEIN; STAINLESS STEEL; STENTS; SWINE; VENA CAVA, INFERIOR;

EID: 77957859548     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1816-5     Document Type: Article

References (25)

1. JM Llovett MI Real X Montana R Planas S Coll J Aponte C Ayuso M Sala J Muchart R Solà J Rodés J Bruix Barcelona Liver Cancer Group 2002 Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739 10.1016/S0140-6736(02)08649-X (Pubitemid 34607087)
2. KT Sato RJ Lewandowski MF Mulcahy B Atassi RK Ryu VL Gates AA Nemcek Jr O Barakat A Benson 3rd R Mandal M Talamonti CY Wong FH Miller SB Newman JM Shaw KG Thurston RA Omary R Salem 2008 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres: safety, efficacy and survival Radiology 247 507 515 10.1148/radiol.2472062029 18349311
3. A Grover HR Alexander 2004 The past decade of experience with isolated hepatic perfusion Oncologist 9 653 664 10.1634/theoncologist.9-6-653 15561809 (Pubitemid 39546406)
4. J Rothbarth RA Tollenaar CJ van de Velde 2006 Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors Expert Rev Anticancer Ther 6 553 565 1:CAS:528:DC%2BD28XktlertrY%3D 10.1586/14737140.6.4.553 16613543 (Pubitemid 44192905)
5. SK Libutti DL Bartlett DL Fraker HR Alexander 2000 Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies J Am Coll Surg 191 519 530 1:STN:280:DC%2BD3M%2FjsFGhsQ%3D%3D 10.1016/S1072-7515(00)00733-X 11085732
6. HR Alexander DL Bartlett SK Libutti JF Pingpank DL Fraker R Royal SM Steinberg CB Helsabeck TH Beresneva 2009 Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal cancer Ann Surg Oncol 16 1852 1859 10.1245/s10434-009-0482-9 19434456
7. SL Noter J Rothbarth ME Pijl JE Keunen HH Hartgrink FG Tijl PJ Kuppen CJ van de Velde RA Tollenaar 2004 Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver Melanoma Res 14 67 72 1:CAS:528:DC%2BD2cXjs1agt74%3D 10.1097/00008390-200402000- 00011 15091197 (Pubitemid 38392417)
8. B van Etten JH de Wilt F Brunstein AM Eggermont C Verhoef 2009 Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases Eur J Surg Oncol 35 539 545 18760560
9. LB van Iersel EJ Hoekman H Gelderblom AL Vahrmeijer EL van Persijn van Meerten FG Tijl HH Hartgrink PJ Kuppen JW Nortier RA Tollenaar CJ van de Velde 2008 Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases Ann Surg Oncol 15 1891 1898 10.1245/s10434-008-9881-6 18470571
10. LB van Iersel H Gelderblom AL Vahrmeijer EL van Persijn van Meerten FG Tijl H Putter HH Hartgrink PJ Uppen JW Nortier RA Tollenaar CJ van de Velde 2008 Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients Ann Oncol 19 1127 1134 10.1093/annonc/mdn032 18304962 (Pubitemid 351796338)
11. LB van Iersel MR Verlaan AL Vahrmeijer EL van Persijn van Meerten FG Tijl RW Sparidans H Gelderblom PJ Kuppen RA Tollenaar CJ van de Velde 2007 Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation Eur J Surg Oncol 33 874 881 17400422
12. HR Alexander SK Libutti JF Pingpank DL Bartlett C Helsabeck T Beresneva 2005 Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy Ann Surg Oncol 12 138 144 10.1245/ASO.2005.05.003 15827794 (Pubitemid 40486622)
13. AL Vahrmeijer JH van Dierendonck HJ Keizer JH Beijnen RA Tollenaar ME Pijl A Marinelli PJ Kuppen JH van Bockel GJ Mulder CJ van de Velde 2000 Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer to the liver Br J Cancer 82 1539 1546 1:CAS:528:DC%2BD3cXjsFaksrg%3D 10.1054/bjoc.2000.1175 10789721
14. J Rothbarth ME Pijl AL Vahrmeijer HH Hartgrink FG Tijl PJ Kuppen RA Tollenaar CJ van de Velde 2003 Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver Br J Surg 90 1391 1397 1:CAS:528:DC%2BD2cXkvFKqtbw%3D 10.1002/bjs.4308 14598420 (Pubitemid 37421675)
15. HJ Zeh III CK Brown MP Holtzman MJ Egorin JL Holleran DM Potter DL Bartlett 2009 A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer Ann Surg Oncol 16 385 394 10.1245/s10434-008-0179-5 19034580
16. JF Pingpank SK Libutti R Chang BJ Wood Z Neeman AW Kam WD Figg S Zhai T Beresneva GD Seidel HR Alexander 2005 Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies J Clin Oncol 23 3465 3474 1:CAS:528:DC%2BD2MXlsVyhsr8%3D 10.1200/JCO.2005.00.927 15908655
17. B van Etten F Brunstein MG van Ijken AW Marinelli C Verhoef JR van der Sijp G Guetens G de Boeck EA de Bruijn JH de Wilt AM Eggermont 2004 Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I-II study Ann Surg Oncol 11 598 605 10.1245/ASO.2004.09.021 15172933 (Pubitemid 40486717)
18. E Savier D Azoulay E Huguet F Lokiec M Gil-Delgado H Bismuth 2003 Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study Arch Surg 138 325 332 10.1001/archsurg.138.3.325 12611582 (Pubitemid 36292668)
19. AM Eggermont MG van Ijken B van Etten JR van der Sijp TL ten Hagen T Wiggers M Oudkerk G de Boeck EA de Bruijn 2000 Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure Hepatogastroenterology 47 776 781 1:STN:280:DC%2BD3M%2FksF2guw%3D%3D 10919031
20. MG van Ijken EA de Bruijn G de Boeck TL ten Hagen JR van der Sijp AM Eggermont 1998 Isolated hypoxic hepatic perfusion with tumor necrosis factor-alfa, melphalan, and mitomycine C using balloon catheter techniques: a pharmacokinetic study in pigs Ann Surg 228 763 770 10.1097/00000658-199812000- 00007 9860475 (Pubitemid 30191687)
21. C Verhoef JH de Wilt F Brunstein AW Marinelli B van Etten M Vermaas G Guetens G de Boeck EA de Bruijn AM Eggermont 2008 Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases: a new simplified technique in isolated hepatic perfusion Ann Surg Oncol 15 1367 1374 10.1245/s10434-007-9714-z 18239976
22. J Harnek W Cwikiel L Bergqvist B Persson H Stridbeck 1996 Isolated liver perfusion using percutaneous methods: an experimental study in the pig Cardiovasc Intervent Radiol 19 418 422 1:STN:280:DyaK2s7kvVSktA%3D%3D 10.1007/BF02577630 8994708
23. MV Beheshti DF Denny Jr MG Glickman W Bodden JC March R Strair TS Ravikumar 1992 Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report J Vasc Intervent Radiol 3 453 458 1:STN:280:DyaK38zosF2muw%3D%3D 10.1016/S1051-0443(92)71988-5
24. J Rothbarth ME Pijl RA Tollenaar F Tijl K Ivancev GJ Mulders PJ Kuppen CJ van de Velde LJ Schultze Kool 2003 An experimental minimally invasive perfusion technique for the treatment of liver metastases Eur J Surg Oncol 29 757 763 1:STN:280:DC%2BD3srisVKgsg%3D%3D 10.1016/j.ejso.2003.08.004 14602496 (Pubitemid 37483950)
25. RF Dondelinger MP Ghysels D Brisbois E Donkers, et al. 1998 Relevant radiological anatomy of the pig as a training model in interventional radiology Eur Radiol 8 1254 1273 1:STN:280:DyaK1czptFyjsg%3D%3D 10.1007/s003300050545 9724449